secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2021-11-12T23:59:59+00:00
Accession:  0001380106-21-000008
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems Q3 commercial revenue $6.3M (+27%); reaffirms FY21 outlook
--------------------------------------------------------------------------------

- Commercial revenue $6.3M (+27% YoY); recurring commercial revenue $2.2M (+154% YoY).
- Net loss of $25.0M includes $8.2M warrant fair-value adjustment and $3.1M debt-repayment charge.
- Cash $220M, no debt; repaid $28.7M term debt in September using IPO proceeds.
- Placed 10 Growth Direct systems and completed validation of 5 customer systems in Q3.
- Reaffirms FY2021 commercial revenue outlook of at least $24M, representing ≥70% YoY growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010621000008/0001380106-21-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010621000008/rpid-20211111x8k.htm
  HTML page:      https://secwatch.observer/filing/0001380106-21-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer